Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation
A Centralized Cord Blood Registry to Facilitate Allogeneic, Unrelated Donor Umbilical Cord Blood Transplantation
1 other identifier
interventional
3,621
1 country
19
Brief Summary
The National Marrow Donor Program (NMDP) has established a system for registering, matching, and tracking unrelated donor cord blood units (CBUs) and transplant outcomes. Study subjects are donors who enroll through collaborating cord blood banks. This study creates uniform collection, screening, testing and storage requirements for cord blood units. The purpose of standardization is to improve efficiency in the selection of cord blood units for transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 leukemia
Started Jan 2000
Longer than P75 for phase_2 leukemia
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2000
CompletedFirst Submitted
Initial submission to the registry
August 15, 2008
CompletedFirst Posted
Study publicly available on registry
August 19, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedJune 21, 2013
June 1, 2013
11.8 years
August 15, 2008
June 12, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Study safety and efficacy for treatment for malignant and non-malignant disorders
annually
Secondary Outcomes (1)
Study relationship between HLA disparity and survival
annually
Study Arms (1)
single arm
EXPERIMENTALHPC, Cord Blood
Interventions
Search for HLA compatible cord blood units using the NMDP registry
Eligibility Criteria
You may qualify if:
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (19)
StemCyte International Cord Blood Center
Covina, California, 91722, United States
Children's Hospital of Orange County Cord Blood Bank
Orange, California, 92868, United States
Ashley Ross Cord Blood Program
San Diego, California, 92103, United States
University of Colorado Cord Blood Bank
Aurora, Colorado, 80218, United States
Bonfils Cord Blood Service
Denver, Colorado, 80230, United States
Lifeforce Cryobanks
Altamonte Springs, Florida, 32701, United States
Gift of Life Marrow Foundation
Boca Raton, Florida, 33431, United States
LifeCord
Gainesville, Florida, 32607, United States
ITxM Cord Blood Services
Glenview, Illinois, 60025, United States
J.P. McMarthy Cord Stem Cell Bank
Detroit, Michigan, 48201, United States
Michigan Community Blood Centers
Grand Rapids, Michigan, 49503, United States
St. Louis Cord Blood Bank
St Louis, Missouri, 63110, United States
CBS - New Jersey Cord Blood bank
Allendale, New Jersey, 07401, United States
Coriell - New Jersey Cord Blood Bank
Camden, New Jersey, 08103, United States
Carolinas Cord Blood Bank
Durham, North Carolina, 27710, United States
Cleveland Cord Blood Center
Cleveland, Ohio, 44128, United States
M.D. Anderson Cord Blood Bank
Houston, Texas, 77030, United States
Texas Cord Blood Bank
San Antonio, Texas, 78201, United States
Puget Sound Blood Center
Seattle, Washington, 98104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John P Miller, M.D., Ph.D.
National Marrow Donor Program
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2008
First Posted
August 19, 2008
Study Start
January 1, 2000
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
June 21, 2013
Record last verified: 2013-06